Mike Mirizzi

Mike Mirizzi currently serves as the Chief Technology Officer at Vantis Vascular since December 2022, bringing extensive experience in research and development. Prior to this role, Mike held the position of Vice President of R&D at Venclose, Inc., which was acquired by Becton Dickinson, from February 2019 onward. Mike also served as Sr. Director of R&D at Spirox, Inc., until its acquisition by Entellus Medical, which was subsequently acquired by Stryker, from March 2016 to December 2018. Additionally, Mike was the Vice President of R&D at QOOL THERAPEUTICS, INC. from January 2014 to January 2016 and co-founded Contact Vascular, Inc., serving as COO during the same period. Mike Mirizzi earned a Bachelor of Science degree in Industrial Engineering from California Polytechnic State University-San Luis Obispo.